跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PREGABALINA TEVA-RATIOPHARM 50 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PREGABALINA TEVA-RATIOPHARM 50 MG CAPSULAS DURAS EFG
Approved
STANDARD
PREGABALINA TEVA-RATIOPHARM 50 MG CAPSULAS DURAS EFG
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 24, 2023
Approval ID
cb685d2004ba40dc
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
cb685d2004ba40dc
Drug Cima Aemps Name
PREGABALINA TEVA-RATIOPHARM 50 MG CAPSULAS DURAS EFG
Register Number
88857
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2023-05-24
Dosage Form
CÁPSULA DURA
Dose
50 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
PREGABALINA
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 24, 2023
Approval ID
cb685d2004ba40dc
Type
Standard
Back to CIMA-AEMPS Approvals
